Immune system activation via adjuvant effect

The term "immune system activation via adjuvant effect" denotes the process by which adjuvants—substances added to vaccines or immunotherapies—enhance and shape the immune response. Adjuvants function primarily by activating innate immune sensors (such as pattern recognition receptors on antigen-presenting cells), resulting in increased cytokine production, improved antigen uptake and presentation, and ultimately more robust and long-lasting adaptive immune responses. This activation is achieved through a variety of molecular pathways depending on the specific adjuvant used. Importantly, while the concept describes a mechanism of action critical for effective vaccination, it is not a single molecular entity nor a therapeutic target itself.

Other names

Immune activation via adjuvantadjuvant-mediated immune activationadjuvant effect on immune system

Agonism of pattern recognition receptors (PRRs) on APCs (e.g., TLR, NOD-like receptors); Activation of inflammasome pathways; Induction of cytokine/chemokine responses creating pro-inflammatory milieus; Enhancement of antigen uptake, processing, and presentation to T and B cells; Depot effect (sustained antigen release)